Accueil / Résultats de recherche pour :

Résultats de recherche pour :

Le remindHIER de BiotechFinances

Tous les jours un bref écho des principales infos de la veille avec le remindHIER de BiotechFinances Deinove (FR0010879056 – ALDEI), composés à haute valeur ajoutée à partir de bactéries rares, notamment du genre Déinocoque, recrute Bernard Scorneaux pour préparer et piloter les études précliniques des composés antibiotiques développés par la …

Plus »

Pour Magnisense la commercialisation c’est maintenant !

Magnisense est aux portes de la commercialisation de ses tests de diagnostic d’urgence des maladies cardio-vasculaires en Europe. Après plusieurs années de recherche et développement, la société dispose désormais du marquage CE pour ses tests et va lancer la commercialisation de ses tests de diagnostic d’urgence des maladies cardio-vasculaires. Ce dispositif mobile …

Plus »

InDevR Launches Next-Generation Software for the Cypher One™ System

Tuesday, March 21st 2017 at 10:00am UTC Next Generation Cypher One™ Software Increases Functionality and Ensures Data Integrity for the Standardization of Hemagglutination and Hemagglutination Inhibition Assays BOULDER, Colo.–(BUSINESS WIRE)– InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, today announced the global launch of …

Plus »

InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at New Jersey’s Cooper Neurological Institute

Monday, March 20th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord …

Plus »

Eleven Biotherapeutics to Present at Oppenheimer’s 27th Annual Healthcare Conference

Monday, March 20th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing a broad pipeline of novel product candidates based on its Targeting Protein Therapeutics (TPTs) platform, today announced that Stephen Hurly, President and Chief Executive Officer, will present a company overview …

Plus »

22nd Century Group Issues Annual Letter to Shareholders

Tuesday, March 21st 2017 at 1:50pm UTC Company believes major licensing contract or strategic partnership could generate hundreds of millions of dollars in annual revenue CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced …

Plus »

Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy

Monday, March 20th 2017 at 2:00pm UTC First study of a liquid biopsy to predict response to immunotherapy Highly accurate with a PPV of 92% and 100% for progression after one and two cycles respectively Early discovery of treatment-induced hyper-progressive disease Published in the peer-reviewed journal, Clinical Cancer Research SAN …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...